T 0094/04 (Cytokine antagonists/REGENERON) of 14.02.2006

European Case Law Identifier: ECLI:EP:BA:2006:T009404.20060214
Date of decision: 14 February 2006
Case number: T 0094/04
Petition for review of: -
Application number: 94930818.3
IPC class: C12N 15/24
Language of proceedings: English
Distribution: Distributed to board chairmen (C)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: Cytokine antagonists
Applicant name: REGENERON PHARMACEUTICALS, INC.
Opponent name: Immunex Corporation
Board: 3.3.08
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2) 1973 European Patent Convention Art 123(3) 1973 European Patent Convention Art 54 1973 European Patent Convention Art 56 1973 European Patent Convention Art 83 1973 European Patent Convention Art 84 1973
Keywords: Admission of revised auxiliary request 2A into the proceedings as main request (yes)
Added matter (no)
Clarity (yes)
Novelty (yes)
Inventive step (yes)
Sufficiency of disclosure (yes)
Catchword: -
Cited cases: T 0019/90 T 0694/92 T 0840/93 T 0794/94
Citing cases: -

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the first instance with the order to maintain the patent on the basis of the following documents:

(a) Claims 1 to 11 filed as revised auxiliary request 2A on 18 October 2005;

(b) Amended description pages 3 to 11 filed during the oral proceedings;